共 50 条
- [6] Long-term Maintenance of Remission with No Dose Escalation Aft er Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation: 3-year Results from the PRECiSE 4 Study [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S448 - S448
- [7] Long-term Maintenance of Remission with No Dose Escalation After Re-induction with Certolizumab Pegol in Patients with Crohn's Disease Exacerbation Who Were Naive to Anti-TNF Treatment: 4-Year Results from the PRECiSE 4 Study [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S418 - S418